169 related articles for article (PubMed ID: 14557985)
1. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar.
Bucheton B; Abel L; El-Safi S; Kheir MM; Pavek S; Lemainque A; Dessein AJ
Am J Hum Genet; 2003 Nov; 73(5):1052-60. PubMed ID: 14557985
[TBL] [Abstract][Full Text] [Related]
2. Genes and environment in susceptibility to visceral leishmaniasis.
El-Safi S; Kheir MM; Bucheton B; Argiro L; Abel L; Dereure J; Dedet JP; Dessein A
C R Biol; 2006 Nov; 329(11):863-70. PubMed ID: 17067929
[TBL] [Abstract][Full Text] [Related]
3. Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan.
Miller EN; Fadl M; Mohamed HS; Elzein A; Jamieson SE; Cordell HJ; Peacock CS; Fakiola M; Raju M; Khalil EA; Elhassan A; Musa AM; Ibrahim ME; Blackwell JM
PLoS Genet; 2007 May; 3(5):e71. PubMed ID: 17500593
[TBL] [Abstract][Full Text] [Related]
4. Multilocus microsatellite typing revealed high genetic variability of Leishmania donovani strains isolated during and after a Kala-azar epidemic in Libo Kemkem district, northwest Ethiopia.
Gelanew T; Cruz I; Kuhls K; Alvar J; Cañavate C; Hailu A; Schönian G
Microbes Infect; 2011 Jun; 13(6):595-601. PubMed ID: 21382503
[TBL] [Abstract][Full Text] [Related]
5. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan.
Bucheton B; Kheir MM; El-Safi SH; Hammad A; Mergani A; Mary C; Abel L; Dessein A
Microbes Infect; 2002 Nov; 4(14):1449-57. PubMed ID: 12475635
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region.
Bucheton B; Abel L; Kheir MM; Mirgani A; El-Safi SH; Chevillard C; Dessein A
Genes Immun; 2003 Mar; 4(2):104-9. PubMed ID: 12618857
[TBL] [Abstract][Full Text] [Related]
7. Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan.
Marquet S; Bucheton B; Reymond C; Argiro L; El-Safi SH; Kheir MM; Desvignes JP; Béroud C; Mergani A; Hammad A; Dessein AJ
J Infect Dis; 2017 Jul; 216(1):22-28. PubMed ID: 28586473
[TBL] [Abstract][Full Text] [Related]
8. Genomewide linkage scan for myopia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 22q12.
Stambolian D; Ibay G; Reider L; Dana D; Moy C; Schlifka M; Holmes T; Ciner E; Bailey-Wilson JE
Am J Hum Genet; 2004 Sep; 75(3):448-59. PubMed ID: 15273935
[TBL] [Abstract][Full Text] [Related]
9. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
[TBL] [Abstract][Full Text] [Related]
10. Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?
Addy M; Nandy A
Bull World Health Organ; 1992; 70(3):341-6. PubMed ID: 1638662
[TBL] [Abstract][Full Text] [Related]
11. Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?
El Hassan AM; Khalil EA
Trop Med Int Health; 2001 Sep; 6(9):743-4. PubMed ID: 11555443
[TBL] [Abstract][Full Text] [Related]
12. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.
Zijlstra EE; el-Hassan AM; Ismael A; Ghalib HW
Am J Trop Med Hyg; 1994 Dec; 51(6):826-36. PubMed ID: 7810819
[TBL] [Abstract][Full Text] [Related]
13. Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
Salih MA; Fakiola M; Abdelraheem MH; Younis BM; Musa AM; ElHassan AM; Blackwell JM; Ibrahim ME; Mohamed HS
BMC Infect Dis; 2014 Dec; 14():662. PubMed ID: 25466928
[TBL] [Abstract][Full Text] [Related]
14. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
el-Hassan AM; Meredith SE; Yagi HI; Khalil EA; Ghalib HW; Abbas K; Zijlstra EE; Kroon CC; Schoone GJ; Ismail A
Trans R Soc Trop Med Hyg; 1995; 89(6):647-52. PubMed ID: 8594683
[TBL] [Abstract][Full Text] [Related]
15. Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north.
el-Hassan AM; Hashim FA; Ali MS; Ghalib HW; Zijlstra EE
Trans R Soc Trop Med Hyg; 1993; 87(4):395-8. PubMed ID: 8249061
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
Singh S ; Kumar J; Singh R; Dwivedi SN
Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
[TBL] [Abstract][Full Text] [Related]
17. Kala-azar epidemic in Varanasi district, India.
Kumar R; Kumar P; Chowdhary RK; Pai K; Mishra CP; Kumar K; Pandey HP; Singh VP; Sundar S
Bull World Health Organ; 1999; 77(5):371-4. PubMed ID: 10361752
[TBL] [Abstract][Full Text] [Related]
18. Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis.
Kuhls K; Keilonat L; Ochsenreither S; Schaar M; Schweynoch C; Presber W; Schönian G
Microbes Infect; 2007 Mar; 9(3):334-43. PubMed ID: 17307010
[TBL] [Abstract][Full Text] [Related]
19. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
[TBL] [Abstract][Full Text] [Related]
20. Post-kala-azar dermal leishmaniasis: recent developments.
Singh S; Sharma U; Mishra J
Int J Dermatol; 2011 Sep; 50(9):1099-108. PubMed ID: 22126871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
